In addition, CCL5+ TAMs within ccRCC tissues exhibited lower levels of immune stimulatory effective molecules (IFNG, PRF1, GZMB, and CD69) and increased expression of immune inhibitory checkpoints (PD-L1, TIM3, TIGIT, LAG3. Here, PRF1 is linked to nonpapillary renal cell carcinoma.